By assessing such studies in “cell viability”/“cell proliferation inhibition” and “apoptotic activity”, these studies exhibited the anti-cancer effects of G-Rk1 in in vitro studies as well as the combined effect of G-Rg5/G-Rk1 (ratio equal 1:1). This evidence concerns the gene GRK1 and cancer.